Adage Capital Partners GP L.L.C. Has $200.84 Million Stock Holdings in Intuitive Surgical, Inc. $ISRG

Adage Capital Partners GP L.L.C. trimmed its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.4% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 369,584 shares of the medical equipment provider’s stock after selling 16,903 shares during the quarter. Adage Capital Partners GP L.L.C. owned approximately 0.10% of Intuitive Surgical worth $200,836,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also added to or reduced their stakes in the company. Vanguard Group Inc. lifted its position in shares of Intuitive Surgical by 2.1% in the 2nd quarter. Vanguard Group Inc. now owns 33,335,833 shares of the medical equipment provider’s stock worth $18,115,025,000 after purchasing an additional 670,302 shares during the period. State Street Corp raised its stake in Intuitive Surgical by 1.2% during the second quarter. State Street Corp now owns 15,552,203 shares of the medical equipment provider’s stock worth $8,451,223,000 after buying an additional 182,871 shares during the last quarter. Geode Capital Management LLC lifted its holdings in Intuitive Surgical by 1.4% in the second quarter. Geode Capital Management LLC now owns 8,188,685 shares of the medical equipment provider’s stock valued at $4,429,590,000 after buying an additional 109,904 shares during the period. Norges Bank acquired a new position in Intuitive Surgical in the second quarter valued at $2,569,260,000. Finally, Invesco Ltd. boosted its position in Intuitive Surgical by 4.8% during the second quarter. Invesco Ltd. now owns 4,421,133 shares of the medical equipment provider’s stock valued at $2,402,488,000 after acquiring an additional 201,159 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, EVP Brian Edward Miller sold 3,500 shares of Intuitive Surgical stock in a transaction on Monday, November 10th. The shares were sold at an average price of $575.00, for a total transaction of $2,012,500.00. Following the transaction, the executive vice president directly owned 5,758 shares of the company’s stock, valued at $3,310,850. The trade was a 37.81% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO David J. Rosa sold 24,500 shares of the stock in a transaction dated Friday, October 24th. The shares were sold at an average price of $547.55, for a total transaction of $13,414,975.00. Following the completion of the sale, the chief executive officer owned 234,256 shares of the company’s stock, valued at approximately $128,266,872.80. This represents a 9.47% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 109,043 shares of company stock worth $60,816,225. 0.70% of the stock is currently owned by insiders.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG opened at $542.32 on Friday. The stock has a market cap of $194.41 billion, a price-to-earnings ratio of 71.74, a PEG ratio of 5.03 and a beta of 1.68. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $616.00. The firm’s 50-day simple moving average is $529.62 and its 200 day simple moving average is $506.00.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, topping the consensus estimate of $1.99 by $0.41. The firm had revenue of $2.51 billion during the quarter, compared to the consensus estimate of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The company’s quarterly revenue was up 22.9% compared to the same quarter last year. During the same period in the prior year, the business posted $1.84 earnings per share. On average, sell-side analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on ISRG. Royal Bank Of Canada set a $625.00 price objective on Intuitive Surgical and gave the stock an “outperform” rating in a research report on Wednesday, October 22nd. The Goldman Sachs Group lifted their target price on Intuitive Surgical from $567.00 to $621.00 and gave the stock a “buy” rating in a report on Wednesday, October 22nd. Zacks Research raised Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a research note on Friday, October 24th. Truist Financial set a $620.00 price objective on shares of Intuitive Surgical and gave the stock a “buy” rating in a research report on Wednesday, October 22nd. Finally, Raymond James Financial set a $603.00 price objective on shares of Intuitive Surgical and gave the company an “outperform” rating in a research note on Wednesday, October 22nd. Two investment analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $608.79.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.